Sunrise Medical ApS: Financial statements 2019
CVR: 37005665
Source: annual report 2019, Danish Business Authority
01/07/2018 – 30/06/2019
Sunrise Medical ApS (CVR 37005665) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 10,923,590 and a net result of DKK -2,839,742 compared with DKK -2,376,956 the year before. That is a decrease of 5% compared with the year before. Equity in the 2019 report amounted to DKK 3,491,815. The solvency ratio was 20.2%. The company had 20 employees in the financial year.
- Gross Profit
- DKK 10,923,590
- Profit/Loss
- DKK -2,839,742
- Equity
- DKK 3,491,815
- Total Assets
- DKK 17,304,974
- Employees
- 20
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 10.9M | -2.8M | 3.5M | 20 |
| 2018 | - | 11.5M | -2.4M | 6.3M | 21 |
| 2017 | - | 11.4M | -3.3M | -3.4M | 20 |
| 2016 | - | 6.4M | -186K | -136K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout Sunrise Medical ApS
Sunrise Medical ApS is a Danish company of the type Anpartsselskab based in Taastrup, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Adrian John Platt and James Louis Barratt. The board consists of Adrian John Platt (chair) and James Louis Barratt. The company is owned by Cidron Ollopa B.V.. The company has 22 employees (2026). In 2024, the company reported a gross profit of DKK 12,726,030 and a net result of DKK 1,921,194 compared with DKK 1,408,512 the year before. Equity in the 2024 report amounted to DKK 6,586,965.